User: Guest  Login
Document type:
Editorial Material
Author(s):
Rexer, H.; Retz, M.; Waller, C.
Title:
An open-label, randomized, Phase III Study of Nivolumab in Combination with Ipilimumab or with Standard Chemotherapy versus Standard Chemotherapy in Patients with previously untreated inoperable or metastatic Urothelial Carcinoma (CheckMate-901) - AB 59/17 of the AUO First-line Therapy for untreated, non-resectable or metastatic Urothelial Carcinoma
Journal title abbreviation:
Urologe A
Year:
2018
Journal volume:
57
Journal issue:
7
Pages contribution:
880-881
Fulltext / DOI:
doi:10.1007/s00120-018-0698-z
Print-ISSN:
0340-2592
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX